Pubertal Suppression and Surgical Management of a Patient with 5-alpha Reductase Deficiency.
Sign Up to like & getrecommendations! Published in 2022 at "Urology"
DOI: 10.1016/j.urology.2022.03.019
Abstract: Five-alpha reductase type 2 deficiency (5αRD2) is a rare cause of atypical genitalia in newborns. There are no definitive guidelines regarding management of children with this disorder. While many children are raised as female given… read more here.
Keywords: patient; management; deficiency; alpha reductase ... See more keywords
SUN-131 Pubertal Suppression for Youth Assigned Female At Birth: Experience With 6-Month Formulations
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.2065
Abstract: Abstract Disclosure: N. Sun: None. M. Vargas Trujillo: Abbvie, Consultant. G. Chelvakumar: None. M. Marinkovic: None. Introduction: Gonadotropin-releasing hormone agonists (GnRHa) are an integral part of gender-affirming care for transgender and non-binary (TG/NB) youth. Within… read more here.
Keywords: month; suppression; suppression youth; youth ... See more keywords
SUN-132 Effectiveness of 6-Month Gnrha Formulations for Pubertal Suppression in Youth Assigned Male-At-Birth
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.2066
Abstract: Abstract Disclosure: N. Sun: None. M. Vargas Trujillo: Abbvie, Consultant. G. Chelvakumar: None. M. Marinkovic: None. Introduction: Pubertal suppression with gonadotropin-releasing hormone agonists (GnRHa) is a core component of gender-affirming care for transgender and non-binary… read more here.
Keywords: month; suppression; youth; pubertal suppression ... See more keywords